Literature DB >> 25709923

Using Markov Chains to predict the natural progression of diabetic retinopathy.

Priyanka Srikanth1.   

Abstract

AIM: To study the natural progression of diabetic retinopathy in patients with type 2 diabetes.
METHODS: This was an observational study of 153 cases with type 2 diabetes from 2010 to 2013. The state of patient was noted at end of each year and transition matrices were developed to model movement between years. Patients who progressed to severe non-proliferative diabetic retinopathy (NPDR) were treated. Markov Chains and Chi-square test were used for statistical analysis.
RESULTS: We modelled the transition of 153 patients from NPDR to blindness on an annual basis. At the end of year 3, we compared results from the Markov model versus actual data. The results from Chi-square test confirmed that there was statistically no significant difference (P=0.70) which provided assurance that the model was robust to estimate mean sojourn times. The key finding was that a patient entering the system in mild NPDR state is expected to stay in that state for 5y followed by 1.07y in moderate NPDR, be in the severe NPDR state for 1.33y before moving into PDR for roughly 8y. It is therefore expected that such a patient entering the model in a state of mild NPDR will enter blindness after 15.29y.
CONCLUSION: Patients stay for long time periods in mild NPDR before transitioning into moderate NPDR. However, they move rapidly from moderate NPDR to proliferative diabetic retinopathy (PDR) and stay in that state for long periods before transitioning into blindness.

Entities:  

Keywords:  Chi-square test; Markov Chains; diabetes mellitus; diabetic retinopathy; transition probability matrix

Year:  2015        PMID: 25709923      PMCID: PMC4325257          DOI: 10.3980/j.issn.2222-3959.2015.01.25

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  19 in total

1.  Estimation of the transition matrix of a discrete-time Markov chain.

Authors:  Bruce A Craig; Peter P Sendi
Journal:  Health Econ       Date:  2002-01       Impact factor: 3.046

2.  Diabetic retinopathy: clinical findings and management.

Authors:  K Viswanath; D D Murray McGavin
Journal:  Community Eye Health       Date:  2003

3.  Development and progression of retinopathy after inpatient management of diabetes.

Authors:  Satsuki Kawasaki; Osamu Hasegawa; Shinobu Satoh; Tatsuya Saito; Haruko Ishio; Harumi Fukushima; Satoshi Kato; Hidetoshi Yamashita; Yasuo Terauchi; Hisahiko Sekihara
Journal:  Intern Med       Date:  2006-12-15       Impact factor: 1.271

Review 4.  Socio-economic burden of diabetes in India.

Authors:  A Ramachandran
Journal:  J Assoc Physicians India       Date:  2007-07

5.  The use of the Markov process in describing the natural course of diabetic retinopathy.

Authors:  S K Garg; G Marshall; H P Chase; W E Jackson; P Archer; M J Crews
Journal:  Arch Ophthalmol       Date:  1990-09

6.  The economic burden of major adult visual disorders in the United States.

Authors:  David B Rein; Ping Zhang; Kathleen E Wirth; Paul P Lee; Thomas J Hoerger; Nancy McCall; Ronald Klein; James M Tielsch; Sandeep Vijan; Jinan Saaddine
Journal:  Arch Ophthalmol       Date:  2006-12

7.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

Review 8.  Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries.

Authors:  L M Ruta; D J Magliano; R Lemesurier; H R Taylor; P Z Zimmet; J E Shaw
Journal:  Diabet Med       Date:  2013-04       Impact factor: 4.359

Review 9.  Angiogenesis--a new target for future therapy.

Authors:  Nilesh M Pandya; Naranjan S Dhalla; Dev D Santani
Journal:  Vascul Pharmacol       Date:  2006-03-20       Impact factor: 5.773

10.  Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan.

Authors:  W-J Liu; L-T Lee; M-F Yen; T-H Tung; R Williams; S W Duffy; T H-H Chen
Journal:  Diabet Med       Date:  2003-09       Impact factor: 4.359

View more
  9 in total

1.  Does delay in referral of proliferative diabetic retinopathy from the diabetic eye screening programme lead to visual loss?

Authors:  G S Negretti; R Amin; L Webster; C A Egan
Journal:  Eye (Lond)       Date:  2016-04-08       Impact factor: 3.775

2.  Multistate Markov model application for blood pressure transition among the Chinese elderly population: a quantitative longitudinal study.

Authors:  Xujuan Zheng; Juan Xiong; Yiqin Zhang; Liping Xu; Lina Zhou; Bin Zhao; Yuxin Wang
Journal:  BMJ Open       Date:  2022-07-14       Impact factor: 3.006

3.  An Efficacy Predictive Method for Diabetic Ulcers Based on Higher-Order Markov Chain-Set Pair Analysis.

Authors:  Le Kuai; Xiao-Ya Fei; Jia-Qi Xing; Jing-Ting Zhang; Ke-Qin Zhao; Kan Ze; Xin Li; Bin Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-16       Impact factor: 2.629

4.  Natural Course of Clinically Isolated Syndrome: A Longitudinal Analysis Using a Markov Model.

Authors:  Yuli Hou; Yujuan Jia; Jingtian Hou
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

5.  Estimating Lifetime Duration of Diabetes by Age and Gender in the Korean Population Using a Markov Model.

Authors:  Seung Woo Cho; Seon Ha Kim; Young-Eun Kim; Seok-Jun Yoon; Min-Woo Jo
Journal:  J Korean Med Sci       Date:  2019-02-28       Impact factor: 2.153

6.  Determining Risk Factors That Affect Progression in Patients with Nonproliferative Diabetic Retinopathy.

Authors:  Dalbert J Chen; Jacky C Kuo; Alex J Wright; Alice Z Chuang; Wenyaw Chan; Robert M Feldman; Eric L Crowell
Journal:  J Ophthalmol       Date:  2021-11-30       Impact factor: 1.909

7.  Reducing Fall-related Revisits for Elderly Diabetes Patients in Emergency Departments: A Transition Flow Model.

Authors:  Wenjun Zhu; Allie DeLonay; Maureen Smith; Pascale Carayon; Jingshan Li
Journal:  IEEE Robot Autom Lett       Date:  2021-05-19

8.  Causes and Clinical Impact of Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy.

Authors:  Hazem Abdelmotaal; Walid Ibrahim; Mohamed Sharaf; Khaled Abdelazeem
Journal:  J Ophthalmol       Date:  2020-02-08       Impact factor: 1.909

9.  A Hybrid Approach for Modeling Type 2 Diabetes Mellitus Progression.

Authors:  Sajida Perveen; Muhammad Shahbaz; Muhammad Sajjad Ansari; Karim Keshavjee; Aziz Guergachi
Journal:  Front Genet       Date:  2020-01-07       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.